Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer
暂无分享,去创建一个
J. Sehouli | S. Nasser | I. Braicu | R. Richter | R. Chekerov | Esra Bilir | K. Pietzner | M. Muallem | A. Babayeva | Melissa-Guelhan Inci
[1] A. Jemal,et al. Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[2] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[3] Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.
[4] K. Stålberg,et al. The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer , 2020, Annals of Surgical Oncology.
[5] Wei Zhang,et al. The maximum standardized uptake value and extent of peritoneal involvement may predict the prognosis of patients with recurrent ovarian cancer after primary treatment , 2020, Medicine.
[6] J. Sehouli,et al. Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer , 2019, International Journal of Gynecological Cancer.
[7] T. Chua,et al. Intraoperative macroscopic tumour consistency is associated with overall survival after cytoreductive surgery and intraperitoneal chemotherapy for appendiceal adenocarcinoma with peritoneal metastases: A retrospective observational study. , 2019, American journal of surgery.
[8] Jae-Weon Kim,et al. A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms , 2019, The New England journal of medicine.
[9] A. Bhatt,et al. Correlation Between Pelvic Peritoneal Disease and Nodal Metastasis in Advanced Ovarian Cancer: Can Intraoperative Findings Define the Need for Systematic Nodal Dissection? , 2019, Indian Journal of Surgical Oncology.
[10] Ting Yu,et al. A retrospective clinical study , 2021 .
[11] J. Esquivel,et al. 2017 Update on Ovarian Cancer Peritoneal Carcinomatosis Multimodal-Treatment Considerations , 2018, Gastroenterology research and practice.
[12] G. Kenter,et al. Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review , 2018, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[13] Jaime Prat,et al. FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication , 2015, Journal of gynecologic oncology.
[14] P. Piso,et al. Prognostic Significance of Sugarbaker’s Peritoneal Cancer Index for the Operability of Ovarian Carcinoma , 2015, International Journal of Gynecologic Cancer.
[15] J. Sehouli,et al. Prognostic and Predictive Value of the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer Patients After Complete Cytoreductive Surgery: Study of Tumor Bank Ovarian Cancer , 2015, Annals of Surgical Oncology.
[16] J. Magrina,et al. Correlation between the extent of intraperitoneal disease and nodal metastasis in node-positive ovarian cancer patients. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[17] R. Zeillinger,et al. Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA–IV: Analysis of the OVCAD Data , 2012, International Journal of Gynecologic Cancer.
[18] J. Magrina,et al. The Impact of Peritoneal Metastases in Epithelial Ovarian Cancer With Positive Nodes , 2011, International Journal of Gynecologic Cancer.
[19] G. Kenter,et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. , 2010, The New England journal of medicine.
[20] Jacobus Pfisterer,et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials , 2009, Cancer.
[21] J. Muntané,et al. Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals , 2007, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[22] Hys Ngan,et al. Carcinoma of the Ovary , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[23] The International Consortium for Outcome Research in H Cancer. The general rules for the gastric cancer study in surgery and pathology , 2006, The Japanese journal of surgery.
[24] H. van Tinteren,et al. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy , 2004, The British journal of surgery.
[25] R. Rouzier,et al. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. , 2003, Journal of the American College of Surgeons.
[26] W. Lichtenegger,et al. „IMO” - Intraoperatives Mapping des Ovarialkarzinoms , 2003 .
[27] L. Weiss. Metastatic inefficiency: intravascular and intraperitoneal implantation of cancer cells. , 1996, Cancer treatment and research.
[28] K. Jablonski,et al. Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy , 1995, Annals of surgery.
[29] Robert C. Wolpert,et al. A Review of the , 1985 .
[30] Tanaki Kajitani,et al. The general rules for the gastric cancer study in surgery and pathology , 1981, The Japanese journal of surgery.
[31] M. A. Meyers. DISTRIBUTION OF INTRA-ABDOMINAL MALIGNANT SEEDING: DEPENDENCY ON DYNAMICS OF FLOW OF ASCITIC FLUID , 1973 .
[32] M. A. Meyers. Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid. , 1973, The American journal of roentgenology, radium therapy, and nuclear medicine.